[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-344440-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-344440-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","enhanced-mrna-expression-of-colonic-il-6-in-cronkhite-canada-syndrome-bearing-colorectal-cancer","Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer","","Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada syndrome (CCS) investigates how immunopathogenesis may drive colorectal cancer development. CCS-associated polyps are benign but transformation into gastrointestinal cancer is the most critical prognostic factor. Because submucosal immune-cell infiltration suggests inflammation-associated carcinogenesis, proinflammatory cytokines were tested in non-cancerous polyps from CCS patients with or without concurrent colorectal cancer. IL-6 mRNA was higher in polyp tissue from patients with concurrent CRC, suggesting IL-6-mediated inflammation as a key mechanism.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/enhanced-mrna-expression-of-colonic-il-6-in-cronkhite-canada-syndrome-bearing-colorectal-cancer/344440/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/enhanced-mrna-expression-of-colonic-il-6-in-cronkhite-canada-syndrome-bearing-colorectal-cancer/344440.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does this study address about CCS-associated colorectal cancer?","Question",{"text":63,"@type":64},"It examines which pathway is critical for CRC development in CCS, focusing on inflammation-associated carcinogenesis driven by proinflammatory cytokines.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were proinflammatory cytokines evaluated in the study?",{"text":68,"@type":64},"mRNA was isolated from non-cancerous CCS-associated polyps and analyzed by reverse transcription quantitative PCR to measure cytokine expression.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cytokine showed enhanced expression, and what does it imply?",{"text":72,"@type":64},"IL-6 showed higher mRNA expression in non-cancerous CCS-associated polyps from patients with concurrent colorectal cancer, suggesting IL-6-mediated inflammation-associated carcinogenesis in transformation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},344440,1790135288,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":111,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":117,"preview_page_count":33,"preview_urls":144},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","doi: 10.21873/invivo.14334  \nEnhanced mRNA Expression of Colonic IL-6 in CronkhiteCanada Syndrome Bearing Colorectal Cancer  \nDAISUKE FUJIHARA, HAJIME HONJO, YASUHIRO MASUTA, YASUO OTSUKA, SHO MASAKI, KOSUKE MINAGA, KEN KAMATA, NAOKO TSUJI, TOMOHIRO WATANABE and MASATOSHI KUDO  \nDepartment of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan  \nAbstract  \nBackground/Aim: Immunosuppressive and nutritional treatments have improved the prognosis ofCronkhite-Canada syndrome (CCS). CCS-associated polyps are benign and categorized into hamartomatous, inflammatory, hyperplastic, and adenomatous polyps; however, the development of gastrointestinal cancer is considered the most significant prognostic factor for CCS. Although the adenoma-carcinoma sequence and inflammation-associated carcinogenesis are two major pathways for the development of colorectal cancers (CRCs), it remains largely unknown which pathway plays critical roles in the development of CRCs in CCS. Inflammation-associated carcinogenesis might be involved in the development of CRCs associated with CCS because CCS-associated polyps are characterized by submucosal infiltration of immune cells. Given the fact that proinflammatory cytokines including interleukin (IL)-6, IL-1β, and tumor necrosis factor (TNF)-α underlie the pathogenesis of inflammation-associated carcinogenesis, we examined the involvement of proinflammatory cytokines in the transformation of CCS-associated polyps into CRCs.  \nPatients and Methods: Three cases of CCS were enrolled: two cases with concurrent CRCs and a single case without CRC. mRNA was isolated from non-cancerous CCS-associated polyps and subjected to reverse transcription quantitative polymerase chain reaction to determine expression of proinflammatory cytokines. Colonic biopsy samples were isolated from non-tumor portions of patients with colonicadenomato determine mRNA expression of proinflammatory cytokines in healthy colonic mucosa.  \nResults: Higher mRNA expression of IL-6, but not IL-1β or TNF-α, in non-cancerous CCS-associated polyps was observed in two patients with CCS and concurrent CRCs as compared with four healthy colonic mucosal samples and a patient with CCS without CRC.  \nConclusion: IL-6-mediated inflammation-associated carcinogenesis might be involved in the transformation of CCSassociated polyps into CRC.  \nKeywords: Cronkhite-Canada syndrome, colorectal cancer, IL-6 .  \n✉ Tomohiro Watanabe, MD, PhD, Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine,  \nMihara-dai 1-14-1, Minami-ku, Sakai, Osaka 590-0197, Japan. Tel: +81 722887222, e-mail: [tomohiro@med.kindai.ac.jp](tomohiro@med.kindai.ac.jp)  \nReceived January 28, 2026 | Revised February 23, 2026 | Accepted February 24, 2026  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n©2026 The Author(s) . Anticancer Research is published by the International Institute of Anticancer Research.  \nIntroduction  \nCronkhite-Canada syndrome (CCS) is a rare disorder characterized by multiple polyps of the gastrointestinal (GI) tract and ectodermal abnormalities, including skin pigmentation, nail atrophy, and hair loss (1, 2) . Multiple polyps with a reddish and erythematous appearance are observed in the gastric and colonic mucosa of patients with CCS (1, 2) . Pathologically, CCS polyps are classified into four types: hamartomatous, inflammatory, hyperplastic, and adenomatous (1, 2) . On microscopic examination, CCS-associated polyps are accompanied by infiltration of immune cells into the submucosa (1-3) . Furthermore, the intervening mucosa between polyps is edematous, and patients with CCS experience severe diarrhea due to protein loss from the GI mucosa (1, 2) .  \nTreatment with prednisolone (PSL) combined with nutritional support improves CCS prognosis. CCS polyps ","cbCaimiSDseNRHDH","https://ap.wps.com/l/cbCaimiSDseNRHDH","pdf",1464373,"English","# Abstract\n## Background/Aim\n## Patients and Methods\n## Results\n## Conclusion\n# Introduction\n# Patients and Methods","[{\"question\":\"What question does this study address about CCS-associated colorectal cancer?\",\"answer\":\"It examines which pathway is critical for CRC development in CCS, focusing on inflammation-associated carcinogenesis driven by proinflammatory cytokines.\"},{\"question\":\"How were proinflammatory cytokines evaluated in the study?\",\"answer\":\"mRNA was isolated from non-cancerous CCS-associated polyps and analyzed by reverse transcription quantitative PCR to measure cytokine expression.\"},{\"question\":\"Which cytokine showed enhanced expression, and what does it imply?\",\"answer\":\"IL-6 showed higher mRNA expression in non-cancerous CCS-associated polyps from patients with concurrent colorectal cancer, suggesting IL-6-mediated inflammation-associated carcinogenesis in transformation.\"}]","Enhanced mRNA Expression of Colonic IL-6 in Cronkhite-Canada Syndrome Bearing Colorectal Cancer | PDF",1790053765,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/02be8185a33996e5488b819699a5ca3f.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2cecec5d2cb45b68306705a0d2f0ecf7.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9952335edb1f71e95f3a8b72db676ffa.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9af2a7d382604403759adadbaa496887.webp",980,1306]